CGEM

Cullinan Oncology LLC

NASDAQ: CGEM · HEALTHCARE · BIOTECHNOLOGY

$14.73

-6.38% today

Updated 2026-06-05

Market cap

$830.30M

P/E ratio

—

P/S ratio

25.86x

EPS (TTM)

$-3.37

Dividend yield

—

52W range

$6 – $17

Volume

0.9M

Market cap

$830.30M

P/E ratio

—

P/S ratio

25.86x

EPS (TTM)

$-3.37

Dividend yield

—

52W range

$6 – $17

Volume

0.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

3.5

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$31.45

+113.51%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy11 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Altman Z 3.51 — safe zone

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-46.05M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$111.21M	$-153.16M	$-167.38M	$-219.88M	$-49.66M
EPS	—	—	—	—	$-3.37
Free cash flow	$-127.80M	$-134.48M	$-145.30M	$-175.80M	$-46.05M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-05-05	MICHAELSON, JENNIFER	Sale	4,000	—
2026-05-05	MICHAELSON, JENNIFER	Sale	7,800	$14.60
2026-05-05	MICHAELSON, JENNIFER	Buy	4,000	$4.30

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CGEM	$830.30M	28	4.3	3.0	5.0	8.0	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Cullinan Oncology LLC trades at $14.73. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 3.51, it sits in the safe zone.

Frequently asked questions

What is Cullinan Oncology LLC's stock price?

Cullinan Oncology LLC (CGEM) trades at $14.73, on a P/S of 25.9x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is Cullinan Oncology LLC overvalued?

Cullinan Oncology LLC carries a Smart Value Score of 28/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Cullinan Oncology LLC (CGEM)?

The 12-month analyst consensus target is $31.45, about 113.5% above the current $14.73. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Cullinan Oncology LLC's Altman Z-Score is 3.51, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio25.86x

ROE-60.36%

Beta0.01

50D MA$14.53

200D MA$11.09

Shares out0.06B

Float0.04B

Short ratio—

Avg volume0.9M

Performance

1 week+0.00%

1 month-14.11%

3 months+0.15%

YTD+30.53%

1 year—

3 years—

5 years—

Compare

CGEM vs LLY →CGEM vs JNJ →CGEM vs ABBV →Stock screener →